TBK1, which phosphorylates optineurin and enhances its binding to ubiquitin chains, is also mutated in ALS patients (Freischmidt et al, 2015; Oakes et al, 2017; Pozzi et al, 2017). The gene discussed is OPTN; the disease is amyotrophic lateral sclerosis.